Panbio登革病毒IgG/IgM診斷試劑盒

廣州健侖生物科技有限公司

本公司為大家供應(yīng)各種進(jìn)口品牌登革熱檢測(cè)試劑盒，包括澳洲Panbio、美國NovaBios、美國CORTEZ等美國CDC品牌。主要包括膠體金、酶免、PCR等方法學(xué)。歡迎咨詢

Panbio登革病毒IgG/IgM診斷試劑盒

非洲工作用登革熱試紙

熱帶國家旅游用登革熱檢測(cè)試紙

登革熱IgM抗體、登革熱IgG抗體、登革熱NS1抗原、登革熱早期檢測(cè)試劑盒

登革熱核酸檢測(cè)試劑盒

Panbio公司簡介:
1、1988年成立，2001年在澳大利亞證券交易所上市。
2、Panbio系關(guān)于蟲媒感染性疾病及熱帶感染性疾病的專業(yè)供貨商。
3、產(chǎn)品面向蟲媒感染性疾病的檢測(cè)，在國內(nèi)疾控系統(tǒng)具有*的認(rèn)知和認(rèn)可度。
4、2010年銷售800萬檢測(cè)試劑，為30多種疾病提供診斷。

Panbio登革熱介紹：

1、登革熱快速檢測(cè)試劑(Dengue Duo Cassette R-DEN03D)
用于定性的快速檢測(cè)人群血清、血漿或全血中登革病毒的IgM及IgG抗體?？稍?5分鐘內(nèi)檢測(cè)結(jié)果。

2、登革IgM捕捉ELISA(Dengue IgM Capture ELISA E-DEN01M)
用于定性的檢測(cè)人群血清中登革病毒的IgM抗體，用于臨床實(shí)驗(yàn)室對(duì)具有持續(xù)發(fā)燒的登革熱癥狀的病人的輔助診斷。

3、登革IgG捕捉ELISA(Dengo IgG Capture ELISA E-DEN02G)
用于定性檢測(cè)血清中登革病毒(血清型1、2、3及4型)的IgG抗體。用于臨床實(shí)驗(yàn)室對(duì)繼發(fā)登革熱感染的輔助診斷。

4、登革早期ELISA(Dengue Early ELISA E-DEN01P)
用于定性檢測(cè)血清中登革病毒的NS1抗原(血清型1、2、3及4型)。用于臨床實(shí)驗(yàn)室對(duì)有持續(xù)發(fā)燒的登革熱癥狀病人的輔助性診斷。

5、登革IgG間接ELISA(Dengue IgG Indirect ELISA E-DEN01G)
用于定性檢測(cè)血清中登革病毒(血清型1、2、3及4型)的IgG抗體，用于臨床實(shí)驗(yàn)室對(duì)具有持續(xù)發(fā)燒的登革感染癥狀或接觸史的患者的輔助性診斷。

6、登革IgM & IgG聯(lián)檢ELISA(Dengue Duo IgM & IgG Capture ELISA E-DEN01D)
用于定性檢測(cè)血清中登革病毒的IgM和IgG抗體?？梢詤^(qū)分原發(fā)感染與繼發(fā)感染。

Dengue產(chǎn)品介紹

Panbio

Panbio登革熱 - 威脅Panbio登革熱是影響兒童zui嚴(yán)重的疾病之一熱帶地區(qū)是由蚊子造成的病毒與那些造成相關(guān)的病毒黃熱病和西尼羅河。更多超過世界人口的40％生活在Panbio登革熱流行地區(qū)和一年多達(dá)1億人變得感染每年都有大概有50萬例孩子，可能是致命的Panbio登革熱出血熱。這份公告是*個(gè)定期報(bào)告Panbio登革熱報(bào)告。我們的目的是為您提供預(yù)防Panbio登革熱努力的簡明扼要的資料，特別是中心的作用疾病控制與預(yù)防（CDC）在這些努力中。在個(gè)*的問題上，我們專注于威脅Panbio登革熱到美國Panbio登革熱世界傳播首先，有一點(diǎn)背景。Panbio登革熱是由四個(gè)密切相關(guān)的病毒引起的，通常被稱血清型（Panbio登革熱-1，-2，-3和-4）。感染一種血清型可引起終身免疫力，但僅限于此血清型有證據(jù)表明隨后的另一種血清型感染增加了機(jī)會(huì)發(fā)展Panbio登革熱出血熱或Panbio登革熱休克綜合征。通常，一種血清型的流行是隨后幾年后，其他一個(gè)流行病。以東南亞為例，大多數(shù)青少年已經(jīng)暴露于多種類型。Panbio登革熱病毒在人類之間的傳播主要是“黃熱病蚊子”的工作，埃及伊蚊。一個(gè)黑色的小黑色蚊子，帶有白色斑紋，埃及伊蚊在所有的除了zui冷的外都興旺發(fā)達(dá)在范圍內(nèi)，包括美國南部的大部分地區(qū)。女性通常8-12天蚊子在感染的人身上飼養(yǎng)，它可以將病毒傳給另一個(gè)人。埃及伊蚊通常在白天叮咬，是*的適應(yīng)生活在人類和周圍人類的棲息地人造容器中的雞蛋，如寵物水碗，花瓶和廢棄的塑料垃圾。還沒有一個(gè)Panbio登革熱疫苗和控制蚊子“載體”是防止傳播的*方法。雖然非常有用，但是有效的蚊子控制難以維持。在未來的問題上，我們將討論工作正在開發(fā)疫苗和創(chuàng)新的蚊蟲防治方法。他的研究和公共衛(wèi)生利益集中在新的評(píng)估和引進(jìn)
疫苗，肝炎病毒的分子流行病學(xué)和循證發(fā)展
公共衛(wèi)生政策?，敻覃愃共┦渴?80位同行評(píng)議的作者或合著者
出版物，包括35本書章或訴訟。我們熱情地歡迎Hal回到CDC和
期待他在與Panbio登革熱的斗爭中的。
CDCPanbio登革熱科
美國的一些疾病和其他國家一樣，
必須由醫(yī)師和醫(yī)院報(bào)告公共衛(wèi)生
當(dāng)局作為建立基線發(fā)生的手段
的疾病或病癥。以這種方式增加以上
基線將及時(shí)引發(fā)公共衛(wèi)生反應(yīng)。這個(gè)
對(duì)傳染病尤其重要，因?yàn)樗?br />允許當(dāng)局提醒社區(qū)增加
健康風(fēng)險(xiǎn)，采取行動(dòng)保護(hù)公眾。在里面
美國CDC負(fù)責(zé)收集和分析這些
數(shù)據(jù)。 2009年6月前，Panbio登革熱不是可報(bào)告的疾病
在美國根據(jù)國務(wù)委員會(huì)的建議
和領(lǐng)土流行病學(xué)家（CSTE），Panbio登革熱病毒
感染，包括Panbio登革熱和Panbio登革熱出血
發(fā)燒，于2010年1月份報(bào)告。
2007年，居住在大陸的美國人中有超過10,500例Panbio登革熱病例報(bào)告
美國及其領(lǐng)土。其中許多案件發(fā)生在400萬美國居民居民當(dāng)中
在波多黎各，美屬維京群島和美國太平洋地區(qū)。不過，有幾例
在加勒比，墨西哥的Panbio登革熱流行國家返回美國大陸的旅客中，
中南美洲，亞太地區(qū)。顯然，Panbio登革熱對(duì)公眾的風(fēng)險(xiǎn)增加
健康在美國。

Panbio

我司還提供其它進(jìn)口或國產(chǎn)試劑盒：登革熱、瘧疾、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌等試劑盒以及日本生研細(xì)菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

想了解更多的Panbio產(chǎn)品及服務(wù)請(qǐng)掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-103室

references：

Panbio dengue fever - global threat Panbio dengue is one of the most serious diseases affecting children. Tropical areas are caused by mosquitoes with viruses associated with those who cause yellow fever and the West Nile. More than 40% of the world's population live in the Panbio dengue epidemic area and as many as 100 million people a year become infected every year about 500,000 children, probably deadly Panbio dengue fever haemorrhagic fever. This announcement is the first periodic report of the Panbio dengue report. Our aim is to provide you with concise and concise information on the global efforts to prevent Panbio dengue efforts, especially the role of the Center for Disease Control and Prevention (CDC) in these efforts. On the first issue, we focus on threatening Panbio dengue to the United States Panbio dengue world spread first, with a little background. Panbio dengue is caused by four closely related viruses, commonly referred to as serotypes (Panbio dengue-1, -2, -3 and -4). Infection of a serotype can cause lifelong immunity, but only in this serotype There is evidence that subsequent serotype infections have increased the chances of developing Panbio dengue hemorrhagic fever or Panbio dengue fever syndrome. Often, a serotype of the epidemic is followed by a few other years after the epidemic. In Southeast Asia, for example, most adolescents have been exposed to multiple types. Panbio dengue virus spread among humans mainly "yellow fever mosquito" work, Aedes aegypti. A black little black mosquito with white markings, Aedes aegypti is thriving all over the world except for the coldest, including most parts of the southern United States. Women usually 8-12 days of mosquitoes are reared in infected people, it can pass the virus to another person. Aedes mosquitoes usually bite during the day and are uniquely adapted to live in humans and humans around the human habitat of artificial containers such as pet water bowls, vases and abandoned plastic waste. There is not a Panbio dengue vaccine and control mosquito "carrier" is the only way to prevent the spread. Although it is very useful, effective mosquito control is difficult to maintain. In future issues, we will discuss the work being developed for vaccines and innovative methods of mosquito control. His research and public health benefits are focused on new assessments and introductions
Vaccine, molecular epidemiology and evidence-based development of hepatitis virus
Public health policy. Dr. Margaret is the author or co-author of 180 peer reviewers
Publications, including 35 books or litigation. We warmly welcome Hal back to CDC and
Looking forward to his leadership in the fight against Panbio dengue fever.
CDCPanbio dengue division
Some of the diseases in the United States, like other countries,
Public health must be reported by physicians and hospitals
The authorities act as a means of establishing a baseline
Of the disease or condition. In this way increase above
The baseline will trigger a public health response in a timely manner. This one
It is especially important for infectious diseases because of it
Allow the authorities to remind the community to increase
Health risks, take action to protect the public. inside
The US CDC is responsible for collecting and analyzing these
data. By June 2009, Panbio dengue fever was not a reportable disease
In the United States according to the recommendations of the Council of State
And territorial epidemiologists (CSTE), Panbio dengue virus
Infections, including Panbio dengue fever and Panbio dengue fever
Fever, reported in January 2010.
In 2007, more than 10,500 cases of Panbio dengue fever were reported among Americans living in the mainland
The United States and its territory. Many of these cases occurred among the 4 million inhabitants of the United States
In Puerto Rico, the US Virgin Islands and the US Pacific region. However, there are several cases
In the Caribbean, the Mexican Panbio dengue epidemic country returned to the American mainland,
Central and South America, Asia Pacific. Obviously, Panbio dengue fever increases the risk to the public
Health in the United States.